Comunicati Stampa
Scienza e Tecnologia

Eccogene announces the addition of Jacques Mizrahi, PhD to Scientific Advisory Board

From 2014 and on, Jacques is a partner of Venture Capital organization, Academic institutions as Inserm Transfert (Paris.France) and member of the board of several biotech companies in Europe. From 2014 and on, Jacques is a partner of Venture Capital organization, Academic institutions as Inserm Transfert (Paris.France) and member of the board of several biotech companies inEurope. "I am very pleased to join the scientific advisory board of Eccogene to help the development of such...

SHANGHAI, 17/06/2021 (informazione.news - comunicati stampa - scienza e tecnologia)

From 2014 and on, Jacques is a partner of Venture Capital organization, Academic institutions as Inserm Transfert (Paris.France) and member of the board of several biotech companies in Europe .

said Dr. Jacques Mizrahi .

" " said Jingye Zhou , PhD, CEO of Eccogene. " "

About Eccogene

Eccogene is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical needs globally. The company focuses on discovery and development of translational medicine in metabolic and immune-related diseases.